NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Net income, 2025
- $479M
- YoY, 2025
- +40.2%
- 5-year CAGR
- +3.3%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $479M | +40.2% |
| 2024 | $341M | +36.7% |
| 2023 | $250M | +61.6% |
| 2022 | $155M | +72.4% |
| 2021 | $90M | −78.0% |
| 2020 | $407M | +1,000.8% |
| 2019 | $37M | +75.4% |
| 2018 | $21M | — |
| 2017 | −$143M | — |
| 2016 | −$141M | — |
| 2015 | −$89M | — |
| 2014 | −$61M | — |
| 2013 | −$46M | — |
| 2012 | $5.0M | −86.6% |
| 2011 | $38M | — |
| 2010 | −$8.0M | — |
| 2009 | −$51M | — |